Improving exercise capacity in lymphoma patients during treatment
Improving Exercise Capacity with a Tailored Physical Activity Intervention in Lymphoma Patients Undergoing Treatment
This study is all about helping lymphoma patients who are getting chemotherapy to stay active and healthy by offering a personalized exercise program that fits their needs, so they can keep their strength up and feel better during treatment.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Wake Forest University Health Sciences NIH-funded |
| Lab location | 1 site (Winston-Salem, United States) |
| Project ID | NIH-10908348 on NIH RePORTER |
What this research studies
This research focuses on enhancing the physical activity levels of lymphoma patients undergoing anthracycline-based chemotherapy, which can lead to cardiovascular issues. The intervention involves a tailored physical activity program that patients can engage in during their treatment, aiming to maintain their exercise capacity and overall health. Patients will receive guidance from cardiac rehabilitation facilities and will be encouraged to participate in community support groups. The program is designed to be adaptable to individual lifestyles and health conditions.
Who could benefit from this research
Good fit: Ideal candidates for this research are lymphoma patients receiving anthracycline-based chemotherapy who are looking to improve their exercise capacity and overall well-being.
Not a fit: Patients who are not undergoing anthracycline-based chemotherapy or those with severe physical limitations that prevent participation in exercise may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could help lymphoma patients maintain their physical health and quality of life during chemotherapy.
How similar studies have performed: Previous research has shown that physical activity interventions can be beneficial for cancer patients, indicating potential success for this tailored approach.
Where this research is happening
Winston-Salem, United States
- Wake Forest University Health Sciences — Winston-Salem, United States (Active)
Researchers
- Principal investigator: Hundley, William Gregory — Wake Forest University Health Sciences
- Study coordinator: Hundley, William Gregory
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.